Literature DB >> 25528859

Multicentric Castleman disease mimicking IgG4-related disease: A case report.

Yasumori Izumi1, Hayato Takeshita1, Yuji Moriwaki2, Keiko Hisatomi3, Masakazu Matsuda1, Natsuki Yamashita1, Chieko Kawahara1, Yoshika Shigemitsu1, Nozomi Iwanaga1, Atsushi Kawakami4, Hirokazu Kurohama5, Daisuke Niino5, Masahiro Ito5, Kiyoshi Migita1.   

Abstract

A 50-year-old woman was referred to our hospital for shoulder joint stiffness. She had a history of polyclonal hypergammaglobulinemia and an elevated C-reactive protein level. Her laboratory data revealed an elevated serum immunoglobulin G4 (IgG4) level, hypergammaglobulinemia, and rheumatoid factor positivity in the absence of anticyclic citrullinated peptide antibody. [18F]-Fluorodeoxyglucose positron emission tomography showed significant [18F]-fluorodeoxyglucose uptake in multiple lymph nodes (axillary, hilar, para-aortic, and inguinal). Biopsy of the inguinal lymph node showed expansion of the interfollicular areas by heavily infiltrating plasma cells, consistent with multicentric Castleman disease (MCD). Immunohistochemical analysis revealed a 37.3% IgG4-positive:IgG-positive plasma cell ratio, indicating overlapping IgG4-related disease. However, serological cytokine analysis revealed elevated levels of interleukin-6 (9.3 pg/ml) and vascular endothelial growth factor (VEGF) (1210 pg/ml), which are compatible with MCD. Corticosteroid treatment resolved the serological and imaging abnormalities. IgG4-related disease can mimic MCD, and it is crucial to distinguish between these two diseases. Serum interleukin-6 and VEGF levels may help to discriminate MCD from IgG4-related disease.

Entities:  

Keywords:  IgG4-related disease; Interleukin-6; Multicentric Castleman disease

Mesh:

Substances:

Year:  2014        PMID: 25528859     DOI: 10.3109/14397595.2014.985356

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  9 in total

1.  Clinical characteristics of a concurrent condition of IgG4-RD and Castleman's disease.

Authors:  Xia Zhang; Panpan Zhang; Linyi Peng; Yunyun Fei; Wei Zhang; Ruie Feng; Wen Zhang
Journal:  Clin Rheumatol       Date:  2018-06-14       Impact factor: 2.980

2.  A special subtype of POEMS syndrome: IgG4 subtype.

Authors:  Miao Zheng; Pan Zhou; Kai Zheng; Li Meng; Xian Liu; Mengdi Chu; Jie Lu; Lingli Dong
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  Perifollicular granulomas with IgG4 plasmacytosis: A case report and review of literature.

Authors:  Li Liang; Jain Zhou; Lei Chen
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

4.  Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases.

Authors:  Satomi Kasashima; Atsuhiro Kawashima; Fuminori Kasashima; Masamitsu Endo; Yasushi Matsumoto; Kengo Kawakami
Journal:  Heart Vessels       Date:  2018-06-21       Impact factor: 2.037

5.  Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease.

Authors:  Mitsuhiro Akiyama; Hidekata Yasuoka; Kunihiro Yamaoka; Katsuya Suzuki; Yuko Kaneko; Harumi Kondo; Yoshiaki Kassai; Keiko Koga; Takahiro Miyazaki; Rimpei Morita; Akihiko Yoshimura; Tsutomu Takeuchi
Journal:  Arthritis Res Ther       Date:  2016-07-13       Impact factor: 5.156

6.  IgG4-positive cell infiltration in various cardiovascular disorders - results from histopathological analysis of surgical samples.

Authors:  Ryoto Hourai; Satomi Kasashima; Koichi Sohmiya; Yohei Yamauchi; Hideki Ozawa; Yoshinobu Hirose; Yasuhiro Ogino; Takahiro Katsumata; Masahiro Daimon; Shu-Ichi Fujita; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  BMC Cardiovasc Disord       Date:  2017-02-03       Impact factor: 2.298

7.  Analysis of Clinical Characteristics, Pathological Changes and Changes of Interleukin-6 (IL-6) and C-Reactive Protein (CRP) in Children with Castleman's Disease.

Authors:  Chao Hu; Yan Zou; Jing Pan; Jiliang Yang; Tianyou Yang; Tianbao Tan; Jiahao Li
Journal:  Med Sci Monit       Date:  2020-08-15

8.  IL-6 expression helps distinguish Castleman's disease from IgG4-related disease in the lung.

Authors:  Yasuhiro Kinugawa; Takeshi Uehara; Mai Iwaya; Shiho Asaka; Shota Kobayashi; Tomoyuki Nakajima; Masamichi Komatsu; Masanori Yasuo; Hiroshi Yamamoto; Hiroyoshi Ota
Journal:  BMC Pulm Med       Date:  2021-07-10       Impact factor: 3.317

9.  Immunoglobulin G4-related lymph node disease with an orbital mass mimicking Castleman disease: A case report.

Authors:  Feng-Yun Hao; Feng-Xia Yang; Hai-Yan Bian; Xia Zhao
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.